{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:49:26Z","timestamp":1792144166017,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-026-03244-9","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:36:55Z","timestamp":1783478215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the safety profile of poliomyelitis vaccines: insights from post-marketing surveillance"],"prefix":"10.1186","volume":"23","author":[{"given":"Gang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Feng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"3244_CR1","unstructured":"Global eradication of poliomyelitis by the year. 2000 [https:\/\/apps.who.int\/iris\/handle\/10665\/175595]"},{"issue":"6","key":"3244_CR2","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/j.1539-6924.2006.00831.x","volume":"26","author":"KM Thompson","year":"2006","unstructured":"Thompson KM, Tebbens RJD. Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Anal. 2006;26(6):1423\u201340.","journal-title":"Risk Anal"},{"key":"3244_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev.pu.13.050192.001323","volume":"13","author":"CA de Quadros","year":"1992","unstructured":"de Quadros CA, Andrus JK, Olive JM, Guerra de Macedo C, Henderson DA. Polio eradication from the Western Hemisphere. Annu Rev Public Health. 1992;13:239\u201352.","journal-title":"Annu Rev Public Health"},{"issue":"36","key":"3244_CR4","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","volume":"33","author":"TT Shimabukuro","year":"2015","unstructured":"Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398\u2013405.","journal-title":"Vaccine"},{"issue":"6","key":"3244_CR5","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","volume":"12","author":"RT Chen","year":"1994","unstructured":"Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12(6):542\u201350.","journal-title":"Vaccine"},{"key":"3244_CR6","volume-title":"Manual for the Surveillance of Vaccine-Preventable Diseases","author":"(CDC) CfDCaP","year":"2024","unstructured":"(CDC) CfDCaP. Manual for the Surveillance of Vaccine-Preventable Diseases. Centers for Disease Control and Prevention; 2024."},{"key":"3244_CR7","unstructured":"MedDRA. Medical Dictionary for Regulatory Activities: MedDRA Hierarchy.21. In.; 2024."},{"issue":"11","key":"3244_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/14740338.2023.2223958","volume":"22","author":"V Battini","year":"2023","unstructured":"Battini V, Carnovale C, Clementi E, Sessa M. Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System. Expert Opin Drug Saf. 2023;22(11):1105\u201312.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"3244_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/14740338.2023.2251390","volume":"23","author":"B Cao","year":"2024","unstructured":"Cao B, Gu S, Shen Z, Zhang Y, Shen Y, Chen H. Evaluating Ubrogepant-related adverse events using the FDA adverse event reporting system. Expert Opin Drug Saf. 2024;23(3):297\u2013303.","journal-title":"Expert Opin Drug Saf"},{"issue":"13","key":"3244_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33417","volume":"10","author":"Z Dai","year":"2016","unstructured":"Dai Z, Wang G, Zhang J, Zhao Q, Jiang L. Adverse events associated with eteplirsen: a disproportionality analysis using the 2016\u20132023 FAERS data. Heliyon. 2016;10(13):e33417.","journal-title":"Heliyon"},{"key":"3244_CR11","unstructured":"Agency EM. Signal Management\u2014Designated Medical Events. In.; 2023."},{"issue":"2","key":"3244_CR12","first-page":"213","volume":"95","author":"E Hernandez Quiroz","year":"2022","unstructured":"Hernandez Quiroz E, Kauffman CL, Kupiec-Banasikowska A. Erythema multiforme following hepatitis A and pneumococcal vaccinations. Yale J Biol Med. 2022;95(2):213\u20135.","journal-title":"Yale J Biol Med"},{"issue":"1","key":"3244_CR13","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.7205\/MILMED-D-13-00270","volume":"179","author":"EB Storie","year":"2014","unstructured":"Storie EB, Perry A. Erythema multiforme following smallpox vaccination. Mil Med. 2014;179(1):e113\u2013115.","journal-title":"Mil Med"},{"issue":"1","key":"3244_CR14","first-page":"25","volume":"34","author":"S Kyung","year":"2025","unstructured":"Kyung S, Rahmati M, Kang J, Lee K, Lee H, Yon DK. Global and Regional Burden of Vaccine-Associated Erythema Multiforme and Their Related Vaccines, 1967\u20132023: An In-Depth Analysis of the World Health Organization Pharmacovigilance Database. Med Princ Pract. 2025;34(1):25\u201338.","journal-title":"Med Princ Pract"},{"key":"3244_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102909","volume":"77","author":"E Kechichian","year":"2024","unstructured":"Kechichian E, Dupin N, Wetter DA, Ortonne N, Agbo-Godeau S, Chosidow O. Erythema multiforme. EClinicalMedicine. 2024;77:102909.","journal-title":"EClinicalMedicine"},{"issue":"6","key":"3244_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/archdischild-2011-301163","volume":"97","author":"M Erlewyn-Lajeunesse","year":"2012","unstructured":"Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch Dis Child. 2012;97(6):487\u201390.","journal-title":"Arch Dis Child"},{"issue":"7","key":"3244_CR17","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/j.vaccine.2019.12.028","volume":"38","author":"JR Su","year":"1999","unstructured":"Su JR, Haber P, Ng CS, Marquez PL, Dores GM, Perez-Vilar S, et al. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999\u20132017. Vaccine. 1999;38(7):1746\u201352.","journal-title":"Vaccine"},{"issue":"6","key":"3244_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/ced.14625","volume":"46","author":"S Tso","year":"2021","unstructured":"Tso S, Satchwell F, Moiz H, Hari T, Dhariwal S, Barlow R, Forbat E, Randeva H, Tan YT, Ilchyshyn A, et al. Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis. Clin Exp Dermatol. 2021;46(6):1001\u201310.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"3244_CR19","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jaci.2016.02.015","volume":"137","author":"FD Finkelman","year":"2016","unstructured":"Finkelman FD, Khodoun MV, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol. 2016;137(6):1674\u201380.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"3244_CR20","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.jaci.2015.07.048","volume":"137","author":"MM McNeil","year":"2016","unstructured":"McNeil MM, Weintraub ES, Duffy J, Sukumaran L, Jacobsen SJ, Klein NP, Hambidge SJ, Lee GM, Jackson LA, Irving SA, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016;137(3):868\u201378.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03244-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03244-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-026-03244-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:31:53Z","timestamp":1792143113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-026-03244-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3244"],"URL":"https:\/\/doi.org\/10.1186\/s12985-026-03244-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript has not been published or presented elsewhere in part or in entirety, and is not under consideration by another journal. All the authors have approved the manuscript and agree with submission to your esteemed journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"230"}}